X4 Pharmaceuticals (XFOR) Shares Outstanding (2017 - 2025)

X4 Pharmaceuticals' Shares Outstanding (Entity) history runs 9 years deep, the most recent figure standing at $5.8 million for Q1 2025.

• Quarterly Shares Outstanding (Entity) rose 3.42% year-over-year to $5.8 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $5.8 million (up 3.42% YoY) and the FY2024 annual result came in at $5.7 million, up 2.1% from the prior year.
• Shares Outstanding (Entity) was $5.8 million for Q1 2025 at X4 Pharmaceuticals, up from $5.7 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $5.8 million in Q1 2025 and bottomed at $780803.0 in Q1 2021.
• A 5-year average of $3.5 million and a median of $4.1 million in 2023 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) surged 430.53% — and 2024, when it increased 2.1%.
• X4 Pharmaceuticals' Shares Outstanding (Entity) stood at $937495.0 in 2021, then soared by 125.85% to $2.1 million in 2022, then surged by 163.57% to $5.6 million in 2023, then gained by 2.1% to $5.7 million in 2024, then increased by 1.6% to $5.8 million in 2025.
• Business Quant data shows XFOR's Shares Outstanding (Entity) at $5.8 million in Q1 2025, $5.7 million in Q4 2024, and $5.6 million in Q3 2024.